Skip to main content

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD.

Position in MRK — Merck & Co., Inc.

CIK 1672142 Singapore, U0

Position in MRK

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$4,005,730
+$2,802,830 QoQ
Shares Held
31,173
+211.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#1,145
of 3,769 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Sep 30, 2022
CallValue
$378,928
CallShares
4,400
PutValue
$378,928
PutShares
4,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. holds $30,306,066 across 7 Drug Manufacturers - General names. MRK ranks #4 (13.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 MRK
Merck & Co., Inc.
This page
31,173 $4,005,730

All Filings in MRK

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,005,730 31,173
2026-03-31 $1,202,900 10,000
2025-12-31 $2,315,720 22,000
2024-06-30 $619,000 5,000
2024-03-31 $923,650 7,000
2022-09-30 $378,928 4,400
2022-09-30 $378,928 4,400
2022-06-30 $401,148 4,400
2022-06-30 $401,148 4,400